Ossiform

What have we been up to lately?
Short answer: quite a lot.

We are launching a quarterly newsletter to share what we have been working on, our progress across key initiatives, and where we are headed next. Each edition brings highlights from the past quarter and a preview of what is coming.

If you would like a closer look at how Ossiform is evolving, you are very welcome to join.

Subscribe via our website or use the form linked below to follow along 👇

Ossiform news: https://ossiform.com/press-releases-and-news/
Direct link to the sign-up form: https://2fzpgw.share-eu1.hsforms.com/2qMP6Ooe5RPmoUKvvUC9gbA

What does it really take to bring bioprinting innovations from bench to bedside? 💡

This Thursday, Ossiform’s CCO, Monica Wellejus, will be speaking at the 3DHEALS webinar “Bench to Bedside: Bioprinting Innovations.”

Alongside bioprinting leaders and experts, Monica will share insights from Ossiform’s work in developing a new generation of 3D printed, bioactive bone substitutes. Drawing on experience across key stages of advancing the technology from early development toward clinical, commercial, and research applications, she brings a commercial perspective to the discussion.

In a newly published 3DHEALS interview, Monica highlighted one of the core challenges facing innovators in the field:

“One of the biggest challenges in 3D printing and bioprinting is that truly novel technologies rarely fit perfectly into existing frameworks. They often challenge established processes, definitions, and expectations.”

She will expand on this challenge, dive deeper into the technology, and share new data during the webinar on April 9th, at 5:00 PM CEST / 11:00 AM ET. Register here: https://3dheals.com/bench-to-bedside-bioprinting-innovations/

Join the conversation and gain insight into what it takes to move these technologies closer to patients 🏥

Read the rest of the interview: https://3dheals.com/from-hope-to-breakthrough-3d-printed-bone-regeneration-at-ossiform/

3dheals